Cosmo Robotics Co., Ltd.

Cosmo Robotics Co., Ltd.

KKRX:439960
5,110.00
KRW
-310.00
(-5.72%)
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
669.48
463.61
353.45
361.8
219.77
Basic EPS, GAAP
-186
-469
-587
-902
-463.94
Free Cash Flow per Basic Share
-439.17
-507.58
-490.73
-483.75
-424.57
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
-108.79
-147.28
-245.86
354.45
1,086.17
Tangible Book Value per Share
-118.92
-168.84
-254.23
335.08
1,066.75
Basic Weighted Avg Shares
9
13
20
24
28
Sales/Revenue/Turnover
5,722
6,229
7,019
8,863
6,107
Operating Margin (%)
-60.55
-75.12
-126.43
-80.96
-183.28
Depreciation Expense
658
490
555
765
766
Net Income, GAAP
-1,590
-6,301
-11,657
-22,096
-12,892
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
-27.78
-101.16
-166.08
-249.31
-211.11
Working Capital
-1,476
-5,185
-10,603
9,510
23,877
LT Debt
1,759
764
379
294
129
Total Equity
-3,157
-4,073
-7,578
14,567
34,876
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-465.78

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,401
1,336
658
LT Borrowings
- -
59
52
LT Finance Leases
294
189
76
Preferred Equity and Hybrid Capital
3,230
- -
- -
Shares Outstanding
32
32
32
Market Capitalization
- -
- -
482,597

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
15,191
12,195
27,857
Cash, Cash Equivalents & STI
4,684
2,194
17,012
Accounts Receivable, Net
4,964
4,324
4,647
Inventories
4,925
4,994
5,263
Total Current Liabilities
5,681
5,247
3,980
Payables & Accruals
- -
- -
- -
ST Debt
1,401
1,336
658
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-292.23%
Free Cash Flow
- -
- -
21.6%
Net Income, GAAP
- -
- -
89.54%
Sales/Revenue/Turnover
- -
- -
26.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
2,482
7,019
2025
1,865
3,402
1,886
1,710
8,863
2026
1,267
1,243
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-587
2025
-55
-853
- -
- -
-902
2026
-108
-259.61
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Ju-Young Oh
Full Time Employees
20
Sector
Health technology
Industry
Medical specialties
Address
Digital-ro 31gil Seoul South Korea 16506
IPO Date
May 11, 2026
Business
Cosmo Robotics Co., Ltd. operates as a global developer and distributor of wearable robotic systems focused on rehabilitation, mobility assistance, and industrial applications. The company designs and manufactures lower-limb gait rehabilitation exoskeletons and walking-support devices for patients with neurological impairment or mobility limitations, consumer- and clinical-use wearable robotic systems, and industrial wearable suits intended to reduce physical strain for workers in labor-intensive environments. Headquartered in Seoul, South Korea, with operations targeting domestic and international markets, Cosmo Robotics positions itself across medical rehabilitation, assistive technology, and industrial automation segments. Main products and services - Wearable medical exoskeletons for lower-limb gait rehabilitation: including devices designed to assist and retrain walking in patients recovering from neurological events or with mobility impairments; software and control interfaces linked to therapy protocols; clinician training and aftercare services - Walking-assistance devices for gait training and mobility support: portable, body-worn robotic assist devices for individuals with reduced mobility or hemiplegia; product variants tailored for pediatric and adult users; accompanying rehabilitation protocols and customer support - Industrial wearable suits and back-support systems: ergonomically designed exosuits and exoskeletons that reduce musculoskeletal load for workers in manufacturing, logistics, and warehousing; integration with safety and productivity workflows; maintenance and service packages - Consumer-accessible wearable robotics: devices aimed at the home and everyday use to assist walking and mobility; consumer education and after-sales service - R&D and customization services: bespoke robotics development for institutional clients, including hospitals, clinics, and industrial operators; integration with existing healthcare IT systems and industrial automation platforms - Training, deployment, and support services: installation, operator training, clinical or industrial onboarding, remote monitoring, and ongoing technical support Latest major company changes - Strategic expansion through planned international growth and IPO readiness: pursuing overseas market expansion in the United States and other regions, with a plan to use capital to accelerate global sales and marketing efforts; focus on regulatory approvals for key devices to broaden access in major markets - FDA/regulatory milestones targeted for key products: aiming for U.S. regulatory clearance for pediatric wearable devices, which would facilitate broader commercialization in the U.S. medical device market - Product portfolio diversification toward consumer-facing offerings: development of personal-use wearable robotics and related devices to transition from predominantly B2B to B2C channels - IPO-related fundraising and corporate restructuring: involvement in capital-raising activities on the KOSDAQ platform to finance international expansion and product development; anticipated reorganizations to support scaled operations and international subsidiaries - Regional market expansion through subsidiaries and distributors: planned establishment or expansion of regional sales subsidiaries and distributor networks in strategic markets, including China, Europe, Russia, and Southeast Asia, to accelerate international penetration Additional context - Industry and segments: wearable robotics; rehabilitation technology; assistive devices; industrial automation and ergonomic wearable solutions - Target markets: hospitals, rehabilitation centers, clinics, long-term care facilities; industrial employers in logistics, manufacturing, and warehousing; individual consumers seeking mobility assistance - Geographic operations: primary emphasis on South Korea with growing presence in North America, Europe, Asia-Pacific regions; subsidiary and distributor networks in multiple countries to support local markets - Founding year and headquarters: established in the early 2010s with headquarters in South Korea; global operations with regional offices or affiliates - Subsidiaries/parent relationships: operates as a global entity with potential subsidiary structures and strategic partnerships to support international sales and regulatory approvals Note: This description reflects Cosmo Robotics Co., Ltd., focusing on its core offerings, recent strategic moves toward expansion, and its positioning across medical rehabilitation, consumer wearables, and industrial wearable solutions. For the latest precise corporate details, including exact product names, regulatory status, and current corporate structure, refer to official disclosures and recent market filings.